Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Kidney Transplant Rejection: later-stage trial registry
3 of 9 indexed Kidney Transplant Rejection trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 3 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Kidney Transplant Rejection: 9 US clinical trials tracked, 3 recruiting.
Kidney Transplant Rejection is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Cedars-Sinai Medical Center, running 2 of these trials.
Enrollment posture brief
Registry condition kidney-transplant-rejection
OPEN 3 | RECR 33% | LATE 1 | EARLY 0 | RANK #1916 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Kidney Transplant Rejection lists 3 open slots (33% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Kidney Transplant Rejection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Kidney Transplant Rejection is recruiting below its size-band peers.
3 of 9 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Kidney Transplant Rejection research.
Cedars-Sinai Medical Center accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Kidney Transplant Rejection enrolment sits around 140 participants.
Median target enrolment is 140 among the 9 trials that report a genuine target (sentinel values excluded). 3 of those (33.3%) plan for fewer than 100 participants.
-
Kidney Transplant Rejection research leans observational.
1 interventional and 8 observational studies make up this index (11.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Trifecta-Kidney cfDNA-MMDx Study
University of Alberta
NCT04239703
Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring
Insight Molecular Diagnostics
NCT07060716
Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA
Virginia Commonwealth University
NCT07415876
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)
Natera
NCT04091984
Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection
Verici Dx
NCT04727788
Microbiome and Immunosuppression: The Mission Study
The University of Texas Medical Branch, Galveston
NCT04953715
Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection
Cedars-Sinai Medical Center
NCT03859388
Transition of Renal Patients Using AlloSure Into Community Kidney Care
CareDx
NCT04601155
Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients
Cedars-Sinai Medical Center
NCT04225988
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Kidney Transplant Rejection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Kidney Transplant Rejection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Kidney Transplant Rejection page
9 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Kidney Transplant Rejection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cedars-Sinai Medical Center sponsors the most Kidney Transplant Rejection trials on record, review their full trial history before evaluating a specific study. See Cedars-Sinai Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Kidney Transplant Rejection condition card totals 9 registered trials; most-linked intervention Prospera; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.